Your browser doesn't support javascript.
loading
Fragment-based discovery of a chemical probe for the PWWP1 domain of NSD3.
Böttcher, Jark; Dilworth, David; Reiser, Ulrich; Neumüller, Ralph A; Schleicher, Michael; Petronczki, Mark; Zeeb, Markus; Mischerikow, Nikolai; Allali-Hassani, Abdellah; Szewczyk, Magdalena M; Li, Fengling; Kennedy, Steven; Vedadi, Masoud; Barsyte-Lovejoy, Dalia; Brown, Peter J; Huber, Kilian V M; Rogers, Catherine M; Wells, Carrow I; Fedorov, Oleg; Rumpel, Klaus; Zoephel, Andreas; Mayer, Moriz; Wunberg, Tobias; Böse, Dietrich; Zahn, Stephan; Arnhof, Heribert; Berger, Helmut; Reiser, Christoph; Hörmann, Alexandra; Krammer, Teresa; Corcokovic, Maja; Sharps, Bernadette; Winkler, Sandra; Häring, Daniela; Cockcroft, Xiao-Ling; Fuchs, Julian E; Müllauer, Barbara; Weiss-Puxbaum, Alexander; Gerstberger, Thomas; Boehmelt, Guido; Vakoc, Christopher R; Arrowsmith, Cheryl H; Pearson, Mark; McConnell, Darryl B.
Affiliation
  • Böttcher J; Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria. jark.boettcher@boehringer-ingelheim.com.
  • Dilworth D; Structural Genomics Consortium, University of Toronto, Toronto, Ontario, Canada.
  • Reiser U; Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.
  • Neumüller RA; Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.
  • Schleicher M; Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.
  • Petronczki M; Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.
  • Zeeb M; Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany.
  • Mischerikow N; Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.
  • Allali-Hassani A; Structural Genomics Consortium, University of Toronto, Toronto, Ontario, Canada.
  • Szewczyk MM; Structural Genomics Consortium, University of Toronto, Toronto, Ontario, Canada.
  • Li F; Structural Genomics Consortium, University of Toronto, Toronto, Ontario, Canada.
  • Kennedy S; Structural Genomics Consortium, University of Toronto, Toronto, Ontario, Canada.
  • Vedadi M; Structural Genomics Consortium, University of Toronto, Toronto, Ontario, Canada.
  • Barsyte-Lovejoy D; Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada.
  • Brown PJ; Structural Genomics Consortium, University of Toronto, Toronto, Ontario, Canada.
  • Huber KVM; Structural Genomics Consortium, University of Toronto, Toronto, Ontario, Canada.
  • Rogers CM; Structural Genomics Consortium, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Wells CI; Target Discovery Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Fedorov O; Structural Genomics Consortium, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Rumpel K; Target Discovery Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Zoephel A; Structural Genomics Consortium, Division of Chemical Biology and Medicinal Chemistry, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Mayer M; Structural Genomics Consortium, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Wunberg T; Target Discovery Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Böse D; Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.
  • Zahn S; Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.
  • Arnhof H; Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.
  • Berger H; Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.
  • Reiser C; Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.
  • Hörmann A; Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.
  • Krammer T; Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.
  • Corcokovic M; Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.
  • Sharps B; Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.
  • Winkler S; Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.
  • Häring D; Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.
  • Cockcroft XL; Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.
  • Fuchs JE; Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.
  • Müllauer B; Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.
  • Weiss-Puxbaum A; Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.
  • Gerstberger T; Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.
  • Boehmelt G; Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.
  • Vakoc CR; Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.
  • Arrowsmith CH; Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.
  • Pearson M; Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.
  • McConnell DB; Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.
Nat Chem Biol ; 15(8): 822-829, 2019 08.
Article in En | MEDLINE | ID: mdl-31285596
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Nuclear Proteins / Histone-Lysine N-Methyltransferase Limits: Humans Language: En Journal: Nat Chem Biol Journal subject: BIOLOGIA / QUIMICA Year: 2019 Type: Article Affiliation country: Austria
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Nuclear Proteins / Histone-Lysine N-Methyltransferase Limits: Humans Language: En Journal: Nat Chem Biol Journal subject: BIOLOGIA / QUIMICA Year: 2019 Type: Article Affiliation country: Austria